Search Results
Search results for "Randy Hall"
Results found for "Randy Hall"
- Terryâs Corner, Celtarys' Leap, and the $7B GPCR Horizon
Hello GPCR Minds,  This week, you'll learn all about Terryâs Pharmacology Corner, your new learning GPCR mutations in cancer  show both driver-like patterns and high redundancy, prompting a call for multiomics
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
Avoid the professional threat of falling behind your peers by accessing the same insights that are driving lessons, classified industry news, priority event alerts, job opportunities, and insider commentaryâall Donât Fall BehindâAccess the Edge You Need đ Become a Premium Member Today ⤠Already a Premium Member
- GPR110, a receptor for synaptamide, expressed in osteoclasts negatively regulates osteoclastogenesis
GPR110 belongs to adhesion GPCR and was the functional receptor of N-docosahexaenoyl ethanolamine (also called
- The Gluopsins: Opsins without the Retinal Binding Lysine
Thus, we call them gluopsins.
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
Topline results from 40 subjects are expected in the second half of the calendar year."
- APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking
APEX2 biosensor utilizes a fluorogenic substrate called Amplex UltraRed (AUR).
- The Hidden Cost of Unclear Biotech Positioning
Investor calls take too long before reaching substance. conversation drifts in a different direction , depending on who is asking the questions 2ď¸âŁ Investor calls In reality, they all point to the same underlying problem .
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...
One successful strategy is the so-called metabolic surgery whose beneficial effects are beyond dietary
- Dr. GPCR and GeneTex Partner to Engage the Community on Anti-GPCR Antibody Challenges
âGPCRs present unique challenges for antibody development,â said Alexander Ball, Jr., M.D., Senior Scientist
- A2B Adenosine Receptor Enhances Chemoresistance of Glioblastoma Stem-Like Cells under Hypoxia: New..
its high chemoresistance and the presence of a cell subpopulation that persists under hypoxic niches, called
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
Letâs build the systems now, before the next delay burns another half a million. đ Book your free 30
- First in Human: Early-stage COVID therapies hold promise against omicron variant
Sotrovimab is the first monoclonal antibody showing preclinical efficacy against all COVID-19 variants , including the delta and omicron mutations, Vir CEO George Scangos said on a Dec. 7 call with analysts
- Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface
Interface from Molecular Dynamics Simulations and Quantum Chemical Calculations "Allosteric modulators are called raises many questions about the ligand interactions and stability, the binding site structure, and how all
- Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair
important role in the modulation of cardiac neurohormonal stress because it is the source of almost all aldosterone, of all epinephrine, and of a significant amount of norepinephrine reaching the failing Particular emphasis is given to findings from the past decade and a half that highlight the emerging β-arrestins in the adrenals, 2 protein families that regulate the signaling and functioning of GPCRs in all
- Murine bone marrow macrophages and human monocytes do not express atypical chemokine receptor 1
ACKR1) was discovered on erythrocytes as the Duffy blood group antigen ( Cutbush et al., 1950 ), also called
- Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026
Latest breakthroughs : Â Lilly confirms Q4 2025 results call; Novo Nordisk explores monthly GLP-1 acquisition
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
. đ Donât Fall BehindâAccess the Edge You Need đ Already a Premium Member?
- Differential binding of Î9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
the receptors the effects are different depending on which signaling pathway is activated, which is called
- Why Intracellular Drugs May Hold the Key to GPCR Therapeutics
New Tools for Getting Drugs Inside Cells All of this hinges on a simple question: can your compound get Persistent binding isnât just about longer half-livesâitâs about smarter pharmacology.
- Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs
All masterclasses â past and upcoming â are included with Premium Membership. On March 12, the University returns live with a half-day session focused on integrated GPCR discovery
- Early Safety Assays: Identifying Showstoppers in GPCR Drug Discovery Pipelines Early
drug discovery, one miscalculated liability can bring an otherwise promising scaffold to a complete halt mechanisms demand immediate attention, and how to build robust decision points into the cascade without falling Single-point thresholds for halting progression Cannot wholly exclude latent risks with a negative result Kenakin, monthly live AMAs, and a growing library of on-demand contentâall focused on sharpening discovery
- đ˘ GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!
Innovation Forum Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568 Call
- Scientific Isolation: The Real Reason Early Biotechs Lose Traction
. đ What it looks like in real life: Meetings end with explanations, not decisions BD calls âwent great
- đ° GPCR Weekly News
Advisory Board with appointment of immuno-oncology experts More millions roll in for Sosei Heptares Call
- How System-Level GPCR Thinking Prevents Discovery Failures
Donât Fall BehindâAccess the Edge You Need Already a Premium Member?
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
Surgery electives meant long nights, constant patient responsibilities, and unpredictable call schedules
- GPCR Selectivity Beyond the Receptor â Live April 9th with Bryan Roth
T This is one of 12+ live Masterclasses planned for 2026 â all included in Premium, each one a direct , 2026, 10 AM EST Join the live discussion ⤠This live session with recording available as well as all Join the live discussion ⤠ This live session with recording available as well as all masterclasses membrane proteome binding dataset enabling AI-driven drug discovery Membrane proteins represent more than half
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
Part 5: Your Precision Blueprint : I'll tie it all together, providing a concise, actionable guide for scientific and operational guidance  to accelerate discovery . đ Book your free 30-minute strategy call
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Sharpen your discovery decisions ⤠GPCR Signal Transduction Call for Papers: Define What Comes Next Volume signals today will shape tomorrowâs breakthroughsâand avoid delays others wonât see coming. đ Access all
- Better GPCR Drug Discovery Decisions Start With Structured Learning
All courses remain included in Premium Membership. Access this weekâs safety framework ⤠GPCRs: Signal Transduction â Volume II (Call for Papers, Deadline




















